Legal & General Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.07B | Sell |
|
|||||
2025
Q1 | $1.1B | Buy |
|
|||||
2024
Q4 | $959M | Sell |
|
|||||
2024
Q3 | $933M | Sell |
|
|||||
2024
Q2 | $877M | Sell |
|
|||||
2024
Q1 | $782M | Buy |
|
|||||
2023
Q4 | $658M | Buy |
|
|||||
2023
Q3 | $594M | Sell |
|
|||||
2023
Q2 | $622M | Buy |
|
|||||
2023
Q1 | $538M | Buy |
|
|||||
2022
Q4 | $487M | Sell |
|
|||||
2022
Q3 | $420M | Sell |
|
|||||
2022
Q2 | $416M | Buy |
|
|||||
2022
Q1 | $476M | Buy |
|
|||||
2021
Q4 | $420M | Sell |
|
|||||
2021
Q3 | $446M | Buy |
|
|||||
2021
Q2 | $416M | Buy |
|
|||||
2021
Q1 | $355M | Sell |
|
|||||
2020
Q4 | $334M | Buy |
|
|||||
2020
Q3 | $346M | Sell |
|
|||||
2020
Q2 | $319M | Sell |
|
|||||
2020
Q1 | $300M | Buy |
|
|||||
2019
Q4 | $397M | Buy |
|
|||||
2019
Q3 | $348M | Sell |
|
|||||
2019
Q2 | $369M | Buy |
|
|||||
2019
Q1 | $329M | Buy |
|
|||||
2018
Q4 | $247M | Buy |
|
|||||
2018
Q3 | $247M | Buy |
|
|||||
2018
Q2 | $200M | Sell |
|
|||||
2018
Q1 | $174M | Sell |
|
|||||
2017
Q4 | $166M | Sell |
|
|||||
2017
Q3 | $197M | Buy |
|
|||||
2017
Q2 | $181M | Buy |
|
|||||
2017
Q1 | $158M | Buy |
|
|||||
2016
Q4 | $133M | Sell |
|
|||||
2016
Q3 | $148M | Buy |
|
|||||
2016
Q2 | $144M | Buy |
|
|||||
2016
Q1 | $111M | Buy |
|
|||||
2015
Q4 | $108M | Sell |
|
|||||
2015
Q3 | $96.6M | Buy |
|
|||||
2015
Q2 | $102M | Buy |
|
|||||
2015
Q1 | $100M | Sell |
|
|||||
2014
Q4 | $76.1M | Sell |
|
|||||
2014
Q3 | $69.8M | Sell |
|
|||||
2014
Q2 | $78.1M | Buy |
|
|||||
2014
Q1 | $82M | Sell |
|
|||||
2013
Q4 | $75.5M | Sell |
|
|||||
2013
Q3 | $74.6M | Sell |
|
|||||
2013
Q2 | $61.8M | Buy |
|